Disease Control Priorities

13 items available

Permanent URI for this collection

Building on its predecessors DCP1 (1993) and DCP2 (2006), the third edition, published by The World Bank Group, provides the most up-to-date evidence on intervention efficacy and program effectiveness for the leading causes of global disease burden. It goes beyond previous efforts by providing systematic economic evaluation of policy choices affecting the access, uptake and quality of interventions and delivery platforms for low-and middle-income countries. Complete volumes of DCP3 will be published electronically and in hard copy in 2015 and 2016. Disease Control Priorities Network (DCPN) at University of Washington’s Department of Global Health, funded by the Bill & Melinda Gates Foundation, promotes and supports the use of economic evaluation for priority setting at both global and national levels through policy advocacy, country engagement, and the production of Disease Control Priorities, Third Edition (DCP3).

Items in this collection

Now showing 1 - 3 of 3
  • Thumbnail Image
    Publication
    Disease Control Priorities, Third Edition: Volume 2. Reproductive, Maternal, Newborn, and Child Health
    (Washington, DC: World Bank, 2016-04-06) Black, Robert ; Laxminarayan, Ramanan ; Temmerman, Marleen ; Walker, Neff ; Black, Robert ; Laxminarayan, Ramanan ; Temmerman, Marleen ; Walker, Neff
    This book focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness and undernutrition in children, principally under age 5. It also covers maternal mortality, morbidity, stillbirth, and influences to pregnancy and pre-pregnancy. It also includes the transition to older childhood, in particular, the overlap and commonality with the child development volume.
  • Thumbnail Image
    Publication
    Disease Control Priorities, Third Edition: Volume 4. Mental, Neurological, and Substance Use Disorders
    (Washington, DC: World Bank, 2016-03-21) Patel, Vikram ; Chisholm, Dan ; Dua, Tarun ; Laxminarayan, Ramanan ; Medina-Mora, Maria Elena ; Patel, Vikram ; Chisholm, Dan ; Dua, Tarun ; Laxminarayan, Ramanan ; Medina-Mora, Maria Lena
    Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.
  • Thumbnail Image
    Publication
    Disease Control Priorities, Third Edition: Volume 3. Cancer
    (Washington, DC: World Bank, 2015-11-12) Gelband, Hellen ; Jha, Prabhat ; Sankaranarayanan, Rengaswamy ; Horton, Susan ; Gelband, Hellen ; Jha, Prabhat ; Sankaranarayanan, Rengaswamy ; Horton, Susan ; Jamison, Dean T. ; Nugent, Rachel ; Laxminarayan, Ramanan
    From its inception, the Disease Control Priorities series has focused attention on delivering efficacious health interventions that can result in dramatic reductions in mortality and disability at relatively modest cost. The approach has been multidisciplinary, and the recommendations have been evidence-based, scalable, and adaptable in multiple settings. Better and more equitable health care is the shared responsibility of governments and international agencies, public and private sectors, and societies and individuals, and all of these partners have been involved in the development of the series. Volume 3, Cancer, presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The DCP3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packages that are cost-effective and suited to low-resource settings.